Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tasimelteon in Jet Lag Type Insomnia (JET8)
NCT03373201Phase 3Completed
- Sponsor
- Vanda Pharmaceuticals Inc.
- Start
- Oct 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tasimelteon in jet lag disorder, sponsored by Vanda Pharmaceuticals Inc.. Started Oct 2017; status: completed.
02
Drugs
tasimelteon
03
Conditions
jet lag disorder
Beyond the preview
Go deeper on NCT03373201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03373201.